Centers of Excellence: Two new publications. One shared vision.  ISGD x GlomCon! Centers of Excellence in Glomerular Disease aim to unite comprehensive patient care, cutting-edge research, clinical trials, education, and equitable access to innovative therapies worldwide. With two complementary consensus papers now published in Kidney International and Kidney International Reports, we have reached an important milestone toward this shared goal. Tobias B. Huber, ISGD’s Founding President, commented, “Together we are turning scientific excellence into global impact, connecting research, innovation, and clinical care for the benefit of patients worldwide.” Ali Poyan Mehr, GlomCon’s Founding President, shared, “Patients everywhere deserve access to expert glomerular care.” These publications lay the groundwork to bring this vision to life together. By joining forces under one unified Centers of Excellence program, we can set shared standards that advance excellence and improve access worldwide. GlomCon and ISGD are now working together to establish a unified global certification program, with final criteria and next steps coming soon! Thank you to all authors, contributors, and partners who helped us reach this milestone. Exciting times ahead! Read the papers here: sciencedirect.com/science/ar… sciencedirect.com/science/ar…

ISGD announces the launch of GD-Kids, a global initiative advancing pediatric glomerular disease research, clinical trials, and collaboration to improve care for children worldwide. Read the press release: is-gd.org/en/news-from-isgd/… #GDKids #ISGD

Lower serum C3 levels are associated with glomerulosclerosis in membranous nephropathy and ANCA-glomerulonephritis academic.oup.com/ckj/advance…

⏰ Time is running out! Registration for the ISGD Clinical Trials Summit 2026 closes October 1. Join leading experts from across the clinical trials and glomerular disease field for important conversations shaping the future of clinical research. Meet the industry experts. Connect with leaders. Be part of what’s next. 📅 November 13–15, 2026 | Galveston, TX 🔗 Register now: is-gd.org/2026-cts #ISGD #ClinicalTrials #GlomerularDisease #KidneyResearch #Nephrology

Clinical trial bootcamp training @ ALANEPE Congress 2026. ISGD is proud to host our Clinical Trials Bootcamp on Oct. 28 in Mar del Plata, Argentina. Looking forward to provide this training to over 120 Latam peds nephs! Learn more: is-gd.org/ctbalanepe #ISGD #ALANEPE2026 #nephtwitter

Don't Wait. Submit Now. Late-Breaking Abstracts Open Through October 1.

🚀 The future of pediatric clinical trials starts here! ISGD Pediatric Clinical Trials Bootcamp is coming to ESPN 2026. Practical training, mentorship & networking to prepare the next generation of trial investigators. 👉 Register now! congressespn.org/ipna-espn-j… #ISGD #ESPN2026 #ClinicalTrials

ISGD meets in Philadelphia.A meaningful visit to the Hospital of the University of Pennsylvania brought together colleagues, clinical perspectives, and important conversations about the future of glomerular medicine.Connecting. Learning. Advancing. Together. @Barb @Tobi @ISGD  #ISGD #GlomerularMedicine #GlomerularDisease #Nephrology #KidneyResearch

Six more experts. Six more perspectives. One big goal. 🔬 Meet more of the incredible speakers joining the ISGD Clinical Trials Summit in Galveston, Nov. 13–15! 🌎 Clinical trials. Collaboration. The future of glomerular medicine. 👉 is-gd.org/2026-CTS

🌊 Your research belongs in Galveston! The ISGD Clinical Trials Summit 2026 is calling for Late Breaking Abstracts! 📅 Opens Sept. 1 ⏰ Deadline Oct. 1 Share your latest research with leaders in glomerular disease. 🔬 Submit: CTS 2026 Late Breaker Info @Barbara58932871 @Tobias_B_Huber @ISGDtweets

Missed the 15th International Podocyte Conference 2025 in Hamburg? 👀 @PodocyteIPC We've got you covered. Dive into this fresh review highlighting the latest advances, emerging concepts, and evolving landscape of podocyte and glomerular disease research as discussed by the scientific community 🌍🔬🧬 👉 Catch up on what’s shaping the field. #PodocyteConference @Tobias_B_Huber @ISGD_la kidney-international.org/act…